The TCM health service market has broad prospects, and the industry is optimistic about four major directions

[Pharmaceutical Network Market Analysis] The big health industry is an important pillar industry related to the national economy and people's livelihood and the national economic development, and the industry prospect is considerable
.

Traditional Chinese medicine has been used in the field of general health for a long time
.

In recent years, with the aging of the population, the continuous upgrading of consumption, and the promotion of a series of favorable policies, the combination of traditional Chinese medicine and general health has been increasingly valued, and the market for traditional Chinese medicine and general health services has broad prospects
.

The industry believes that looking forward to the "14th Five-Year Plan" of traditional Chinese medicine, there are four major directions that are optimistic, namely, traditional Chinese medicine diagnosis and treatment, traditional Chinese medicine OTC, formula granules and traditional Chinese medicine innovative drugs
.

TCM diagnosis and treatment market is expected to grow rapidly TCM diagnosis and treatment services are one of the important business segments of TCM health, and the market will be huge in the future
.

According to Frost & Sullivan, the market size of TCM diagnosis and treatment services is expected to reach RMB 1,839 billion in 2030, with a compound annual growth rate of 18.
2%
.

Securities sources believe that the direction of TCM diagnosis and treatment services has received policy support and is in a period of rapid growth.
It is recommended to pay attention to Gushengtang, the leader of the private TCM chain
.

In the context of centralized procurement, compared with traditional Chinese medicine prescription drugs, because the main sales market of traditional Chinese medicine OTC is in pharmacies, it is expected to avoid the risks of centralized procurement, and the investment value is further highlighted
.

In addition, the OTC out-of-hospital market of traditional Chinese medicine has independent pricing power, and the products can maintain a high profit margin
.

In addition, traditional Chinese medicine OTC also has the attributes of brand consumption, and the downstream demand is relatively stable
.

Securities sources suggest to focus on two directions, one is the targets with exclusive varieties and confidential varieties, with high intellectual property barriers, such as Tong Ren Tang, Pien Tze Huang, Jianmin Group, etc.
; the second is targets with omni-channel coverage and brand strength, including China Resources Sanjiu, Taiji Group, Lingrui Pharmaceutical, etc.

.

 　　The pilot of the formula granule market has ended.
From November 1, 2021, the pilot work of traditional Chinese medicine formula granules for more than 20 years has ended.
The sales scope of traditional Chinese medicine formula granules will be liberalized, and the record-keeping system will be implemented.
Enterprises need to have the ability to trace the whole process and manage risks.
, the industry has huge opportunities, and the market size is expected to continue to grow
.

According to data from the Ministry of Industry and Information Technology, the market size of traditional Chinese medicine formula granules in 2020 is about 53.
3 billion yuan
.

The industry predicts that by 2023, the industry scale is expected to exceed 50 billion yuan
.

 　　Securities people are optimistic about the leading companies that can provide high-quality Chinese herbal decoction pieces/formula granules under the trend of traceability of Chinese herbal medicines
.

 　　Innovative research and development of traditional Chinese medicine is expected to rise rapidly It is understood that compared with western medicine, the research and development cost of innovative traditional Chinese medicine is lower, and the risk is also smaller
.

In addition, the policy also supports the innovative research and development of traditional Chinese medicines.
According to the Classification of Traditional Chinese Medicine Registration and Application Materials Requirements, the registration of traditional Chinese medicines is classified according to innovative traditional Chinese medicine drugs, new improved traditional Chinese medicine drugs, traditional Chinese medicine compound preparations with ancient classic prescriptions, and drugs with the same name and the same formula.
The top three All belong to new Chinese medicines
.

 　　In recent years, the speed of application, approval and listing of new Chinese medicines has been significantly accelerated
.

Among them, in 2021, a total of 12 new Chinese medicines have been approved for marketing, hitting a new high in the past five years
.

Some institutions predict that the approval and marketing of new Chinese medicines will be accelerated in the future, and the number of new Chinese medicines listed on the market may exceed 20 each year
.

 　　Securities sources believe that the competition in the field of innovative traditional Chinese medicine is good, and drug research and development has entered a period of intensive cashing.
It is recommended to pay attention to Yiling Pharmaceutical, Xintian Pharmaceutical, and Guizhou Sanli
.

 　　Disclaimer: Under no circumstances shall the information or opinions expressed in this article constitute investment advice to anyone
.